Monday, June 8, 2020

BURDOCK (Arctium lappa L. +++ )


HERBAL
MEDICINAL
PLANT
----------------------------------------------------------












BURDOCK

Arctium lappa L. +++


BY



RETTODWIKART THENU





BURDOCK
(buhr’dahk)



Arctium lappa L. +++


SUMMARY AND PHARMACEUTICAL COMMENT

The chemistry of burdock and related Arctium species is well documented. Various pharmacological activities have been reported in animals, although none support the reputed herbal uses and there is a lack of rigorous clinical research assessing the effects of burdock. Documented bitter constituents, however, may explain the traditional use of burdock as an orexigenic. In view of the lack of toxicity data, excessive use of burdock should be avoided.

TRADE NAMES
Burdock Root (available from numerous manufacturers).

OTHER COMMON NAMES
Bardane, beggar’s buttons, clotbur, cockle buttons, cuckold, edible burdock, fox’s clote, gobo, great bur, great burdock, happy major, hardock, lappa, love leaves, personata, philanthropium, thorny burr, wild gobo

DESCRIPTION
MEDICINAL PARTS: The medicinal parts of the plant are the ripe seed and the fresh or dried roots.
FLOWER AND FRUIT: The crimson flowers grow in longpeduncled, loose cymes. The heads are fairly large, globose and almost glabrous. All flowers are funnel-shaped and androgynous. The bracts are green and coriaceous with a barb shaped inward-curving tip. The fruit is compressed arid has a bristly tuft, which falls off easily. The fruits separate from their stems on ripening.
LEAVES, STEM AND ROOT: The plant grows to a height of 80 to 150 cm. The stem is erect, rigid, grooved, branched and downy to wooly. The leaves are alternate, petiolate, broad to ovate-cordate. They are blunt and slightly wooly to hairy on the underside. The lowest leaves are very large and have a latex-filled stem.
HABITAT: Burdock grows in Europe, northern Asia and North America.
PRODUCTION: Burdock root consists of the fresh or dried underground parts of Arctium lappa, Arctium minus and/or Arctium tomentosum. Roots are gathered in the autumn of the plant's first year or the early part of the second year.


SPECIES (FAMILY)
Arctium lappa L.  Arctium minus

SYNONYM(S)

A. edule (Siebold ex Miq.) Nakai, Lappa edulis Siebold ex Miq., L. major Gaertn., L. officinalis All.
Arctium majus Bernh., Bardanae Radix, Greater Burdock

ORIGIN
Burdock is a perennial found in China, Europe, and the United States.

PHARMACOPODIAL AND OTHER MONOGRAPHS
BHC 1992(G6)
BHP 1996(G9)
Martindale 35th edition(G85)

LEGAL CATEGORY (LICENSED PRODUCTS)
GSL(G37)

CONSTITUENTS
The following is compiled from several sources, including General References G6 and G75.
Acids Acetic acid, butyric acid, caffeic acid, chlorogenic acid, gamma-guanidino-n-butyric acid, a-guanidino-n-isovaleric acid, trans-2-hexenoic acid, isovaleric acid, lauric acid, linoleic acid, linolenic acid, myristic acid, oleic acid, palmitic acid, propionic acid, stearic acid and tiglic acid.(1–3)
Aldehydes Acetaldehyde, benzaldehyde, butyraldehyde, caproicaldehyde, isovaleraldehyde, propionaldehyde and valeraldehyde.(1)
Carbohydrates Inulin (up to 45–50%), mucilage, pectin and sugars.
Polyacetylenes 0.001–0.002% dry weight. Fourteen identified compounds include 1,11-tridecadiene-3,5,7,9-tetrayne (50%), 1,3,11-tridecatriene-5,7,9-triyne (30%) and 1-tridecen-3,5,7,9,11- pentayne as the major components.(4)
Terpenoids Sesquiterpenes arctiol, b-eudesmol, fukinone, costus acid, dehydrocostus lactone, arctiopicrin.(5)
Thiophenes Arctinone-a, arctinone-b, arctinol-a, arctinol-b, arctinal, arctic acid-b, arctic acid-c, methyl arctate-b and arctinone-a acetate (sulfur-containing acetylenic compounds).(6, 7)
Other constituents Fats (0.4–0.8%), fixed and volatile oils (0.07– 0.18%), bitters (lappatin), resin, phytosterols (sitosterol and stigmasterol), tannin(8) and arctiin, arctigenin and other lignans.( 9–12)
Other species Flavonol (kaempferol, quercetin) glycosides are present in Arctium minus (Hill) Bernh.(3)

ACTIONS AND PHARMACOLOGY
COMPOUNDS
Volatile oil (small amounts) of very complex make-up: including, among others, phenylacetaldehyde, benzaldehyde, 2-alkyl-3-methoxy-pyrazines
Lignans: neoarchtiin A
Sesquiterpene lactones
Polyynes: chief components are trideca-l, ll-dien-3, 5,7,9- tetrain, as well as sulfur derivatives
Caffeic acid derivatives: including chlorogenic acid, isochlorogenic acid
Polysaccharides: insulin (fructose), mucilage's (xyloglucans,acidic xylans)
Triterpenes: including alpha-amyrin, omega-taraxasterol, present to some extent as acetic acid ester
Phytosterols: beta-sitosterol, stigmasterol, campesterol and their esters
Tannins


USES
USES
Burdock seeds are used for their hypotensive, myodepressant, and renotropic properties. Burdock roots are used for their hypoglycemic, antiseptic, toxicopectic, and antitumor actions. Burdock is used for skin disorders such as psoriasis, eczema, poison ivy, boils, and canker sores. Burdock compresses can soothe the swelling of arthritis, rheumatism, and hemorrhoids. It is also commonly used in food, especially in Chinese populations (Jellin et al, 2008).

FOOD USE
Burdock is listed by the Council of Europe as a natural source of food flavouring (category N2). This category indicates that burdock can be added to foodstuffs in small quantities, with a possible limitation of an active principle (as yet unspecified) in the final product.(G16)
HERBAL USE
Burdock is stated to possess diuretic and orexigenic properties. It has been used for cutaneous eruptions, rheumatism, cystitis, gout, anorexia nervosa, and specifically for eczema and psoriasis.(G2,


Figure 1. Burdock (Arctium lappa).

 
Figure 2. Burdock – dried drug substance (root).


ACTIONS

Burdock’s actions include a depurative, mild laxative, and mild diuretic (Mills, Bone, 2005).
Hypoglycemic Action
The inulin content of burdock root makes up approximately 60% of its weight. When used to treat diabetes in rats, Arctium lappa extract caused a long-lasting reduction in blood glucose and an increased tolerance of carbohydrate (Lapinina et al, 1964).
Antimicrobial Action
The roots of Arctium spp. have demonstrated antibacterial activity against Staphylococcus spp., and two compounds present in the fresh root have been found to possess antifungal and antibacterial properties. Arctium was active in vitro against the gram-negative organisms Escherichia coli and Pseudomonas aeruginosa; against the gram-positive organism Staphylococcus aureus; and against the fungi Microsporum gypseum, Trichophyton spp., and Epidermophyton fl occosum (Reisch et al, 1967; Pereira et al, 2005; Gentil et al, 2006). These actions were lost when the roots were dried.
Antitumor Action
A polymer from burdock root may assist in the prevention of cancer by decreasing mutagens, possibly by adsorption (Morita et al, 1984, 1985). An extract of A. lappa root also decreased tumor growth (Foldeak et al, 1964). Burdock showed antiproliferative and apoptotic effects by action of arctigenin, one of the compounds in this herb (Matsumoto, 2006).
Other Actions
One study identifi ed a hepatoprotective effect of burdock. Mice were injected with carbon tetrachloride or acetaminophen. A. lappa was able to reverse hepatic effects (Lin et al, 2000, 2002).

PHARMACOLOGICAL ACTIONS
IN VITRO AND ANIMAL STUDIES
The roots and leaves of burdock plants not yet flowering are stated to possess diuretic, hypoglycaemic and antifurunculous properties.(7) A burdock extract (plant part not stated) was reported to cause a sharp, long-lasting reduction in the blood sugar concentration in rats, together with an increase in carbohydrate tolerance and a reduction in toxicity.(13)
The antimicrobial activity documented for burdock has been attributed to the polyacetylene constituents,(4) although only traces of these compounds are found in the dried commercial herb.(G62) Furthermore, arctiopicrin is stated to be a bitter with antibiotic activity against Gram-positive bacteria.(7, 14) Antibacterial activity against Gram-positive (e.g. Staphylococcus aureus, Bacillus subtilis, Mycobacterium smegmatis) and Gram-negative (Escherichia coli, Shigella flexneri, Shigella sonnei) bacteria has been documented for burdock leaf and flower, whereas the root was only found to be active towards Gram-negative strains.(15)
In vivo uterine stimulant activity has been reported.(G30) Protection against mutagenic activity has also been documented for burdock.(9, 16, 17) Burdock reduced the mutagenicity to Salmonella typhimurium (TA98, TA100) of mutagens both requiring and not requiring S9 metabolic activation.(10) A lignan-like structure was proposed for the desmutagenic factor.(9) In vivo studies have shown that fresh or boiled plant juice from burdock may cause a significant reduction in DMBA-induced chromosome aberrations.(17) Burdock has been reported to exhibit antitumour activity.(18) The addition of dietary fibre (5%) from burdock roots to the diet of rats has been documented to provide protection against the toxicity of various artificial food colours.(19)

CLINICAL STUDIES
There is a lack of clinical research assessing the effects of burdock and rigorous randomised controlled clinical trials are required.

ACTIVITIES
Alterative (f; CRC; PED); Antibacterial (1; APA; CAN; PED); Antidiabetic (1; FNF); Antifuruncular (1; CAN); Anti-HIV (f; APA); Antileukemic (1; FNF); Antilymphomic (1; FNF); Antimutagenic (1; APA; CAN); Antiphlegmatic (f; CRC); Antipyretic (f; CRC; FNF); Antirheumatic (f; PNC); Antiseptic (1; CRC; PNC; SKY); Antitumor (1; APA; CRC; SKY); Aperitif (f; CAN); Astringent (f; PED); Bifidogenic (1; AKT; FNF); Bitter (1; CAN); Carminative (f; CRC); Choleretic (1; APA; FAD); Cytoprotective (1; CAN); Demulcent (1; SKY); Depurative (f; APA; FAD; PHR); Desmutagenic (1; PNC); Detoxicant (1; CAN); Diaphoretic (f; APA; PHR; WAM); Digestive (1; SKY); Diuretic (1; APA;CAN;WAM); Fungicide (1; APA; PED); Gastrostimulant (1; FNF); Hepatotonic (1; WAM); Hypocholesterolemic (1; FNF); Hypoglycemic (1; APA; PNC; SKY); Immunomodulator (1; FNF); Immunostimulant (1; FNF); Lipolytic (1; FNF); Lymphotonic (1; WAM); Prebiotic (1; AKT; FNF); Stomachic (f; CRC); Uterotonic (1; CAN).

INDICATIONS
Abscess (f; CRC); Acne (f; CRC; SKY); Adenopathy (1; CRC; FNF; JLH); Alopecia (f; APA); Anorexia (f; CAN); Arthrosis (f; APA; CRC; PNC); Backache (f; APA); Bacteria (1; APA; CAN; PED); Bladder Stone (1; APA; CRC); Boil (1; CAN; WAM); Bruise (f; CRC; FAD); Bunion (f; CRC); Burn (f; FAD); Cancer (1; APA; CAN; FNF); Cancer, breast (1; FNF; JLH); Cancer, colon (1; FNF; JLH); Cancer, knee (1; FNF; JLH); Cancer, lip (1; FNF; JLH); Cancer, liver (1; FNF; JLH); Cancer, sinus (1; FNF; JLH); Cancer, stomach (1; FNF; JLH); Cancer, tongue (1; FNF; JLH); Cancer, uterus (1; FNF; JLH); Canker Sore (f; APA; CRC); Chancre (f; DEM); Childbirth (f; CRC); Cold (f; APA); Constipation (f; APA; FAD); Corn (f; JLH); Cystosis (f; CAN); Dermatosis (1; APA; CAN; WAM); Diabetes (1; CAN; CRC); Dropsy (f; CRC); Dyspepsia (f; APA); Eczema (f; APA; CAN; WAM); Enterosis (f; APA); Eruption (f; CRC); Fever (f; APA; CRC; FNF; PHR; WAM); Flu (f; APA; FAD); Fungus (1; APA; PED); Furuncle (1; CAN); Gas (f; CRC); Gastrosis (f; APA); Gonorrhea (f; CRC); Gout (f; APA; CAN; FAD); Gravel (f; DEM); Hepatosis (f; FAD); High Cholesterol (1; FNF); HIV (f; APA); Hives (f; FAD); Hyperglycemia (1; APA; CAN; PNC; SKY); Hysteria (f; CRC); Ichthyosis (f; PHR); Immunodepression (1; FNF); Impotence (f; CRC); Induration (f; JLH); Infection (1; APA; CRC; PED; PNC); Inflammation (f; JLH); Itch (f; CRC); Kidney Stone (1; APA; X7860196); Leukemia (1; FNF); Leukorrhea (f; CRC); Lumbago (1; CRC); Lymphoma (1; FNF; JAD); Measles (f; CRC; FAD); Mycosis (1; APA; PED); Nephrosis (f; CRC; FAD); Pain (f; APA); Parturition (f; APA); Pharyngosis (f; APA); Phosphaturia (f; CRC); Psoriasis (1; APA; CAN; WAM); Rheumatism (1; APA; CAN; CRC; PNC); Ringworm (f; CRC); Scarlet Fever (f; FAD); Sciatica (1; APA; CRC); Scirrhus (f; JLH); Scrofula (f; CRC; FAD); Shigella (1; FNF); Smallpox (f; CRC; FAD); Snakebite (f; CRC); Sore (f; APA; CRC; FAD); Staphylococcus (1; FNF); Sterility (f; CRC); Swelling (f; CRC); Syphilis (f; APA; CRC); Tumor (1; APA; CAN; CRC; JLH; SKY); Ulcer (f; APA; JLH); Urethrosis (Unapproved KOM); UTI (f; APA); VD (f; CRC); Vertigo (f; CRC; FAD); Wart (f; APA; JLH); Water
Retention (1; APA; CAN; WAM); Wound (f; APA).

INDICATIONS AND USAGE
Unproven Uses: Preparations of Burdock Root are used for ailments and complaints of the gastrointestinal tract, as a diaphoretic and diuretic, and for blood purifying. Externally, they are used for ichthyosis, psoriasis and seborrhea of the scalp. The claimed efficacies have not been documented.
Chinese Medicine: Burdock is used to treat carbuncles, ulcers and erythema of the skin as well as sore throats. Efficacy has not been proven.

PRODUCT AVAILABILITY
Capsules: 425, 475 mg; cream; salve; fl uid extract; root; tea; tincture
PLANT PARTS USED: Dried roots (most active, used part), leaves, seeds

DOSAGES
DOSAGES
·         Adult PO decoction: 1 cup tid-qid
·         Adult PO fl uid extract: 1-3 ml bid
·         Adult PO tincture of root: 3-5 ml bid-qid
·         Adult topical: apply as compress or as a cream prn

DOSAGES
Dosages for oral administration (adults) for traditional uses recommended in older and contemporary standard herbal reference texts are given below.
·         Dried root   2–6 g by infusion three times daily.(G7)
·         Liquid extract   2–8mL (1 : 1 in 25% alcohol) three times daily.(G7)
·         Tincture   8–12mL (1 : 10 in 45% alcohol) three times daily.(G7)
·         Decoction   500 mL (1 : 20) per day.(G7)

DOSAGES
·         0.25–0.5 cup fresh root (PED); 1.25 tsp chopped or powdered root/cup water (1 tsp = ~2 g) (APA; BIS);
·         2–6 g dry root as tea, 3 ×/day (CAN); 6–12 g dry root (PED); 9 g dry root:45 ml alcohol/45 ml water (PED);
·         2–8 ml liquid root extract (1:1 in 25% ethanol) 3 ×/day (CAN); 8–12 ml root tincture (1:10 in 45% ethanol) 3 ×/day (CAN); 0.5–1 tsp tincture up to 3 ×/day (APA);
·         3 (475 mg) capsules 3 ×/day (APA; NH); 3 (470 mg) capsules 3 ×/day (NH); 0.5–2 ml liquid seed extract (PNC).

DOSAGES
MODE OF ADMINISTRATION: Administered as a drug and, for external use, in the form of burdock oil (extract with fat oil).
HOW SUPPLIED:
Capsules — 460 mg and 475 mg
Fluid Extract — l:l


PRECAUTIONS AND ADVERSE REACTIONS

No health hazards or side effects are known in conjunction with the proper administration of designated therapeutic dosages. There is a slight potential for sensitization via skin contact with the drug.

CONTRAINDICATIONS, INTERACTIONS, AND SIDE EFFECTS
CLASS 1 (AHP). CAN notes that it may conflict with other hypoglycemic medications. Physicians in Burgos, Spain, in 1995, reported three cases of contact dermatosis caused by burdock root poultices. Herbs for Health (November/ December) page 68, reviewing Rodriguez, P. et al., 1995. Allergic contact dermatitis due to burdock. Contact Dermatitis 33(2):134–5. (However, a letter from Alvaro Palacios in Spain tells me this is based on contamination with belladonna). Should be avoided during pregnancy due to a slight estrogenic effect (WAM). CAN also cautions that because it is a uterine stimulant, in vivo, its use in pregnancy and lactation is to be avoided (CAN).

CONTRA-INDICATIONS, WARNINGS
Drug interactions None documented. However, the potential for burdock to interact with other medicines administered concurrently, particularly those with similar or opposing effects, should be considered. For example, there is limited evidence from preclinical studies that burdock (not further specified) has hypoglycaemic activity.
Pregnancy and lactation In vivo uterine stimulant action has been reported.(G30) In view of this, and the lack of toxicity data, the use of burdock during pregnancy and lactation should beavoided.

CONTRAINDICATIONS
Pregnancy category is 2; Breastfeeding category is 2A.
Burdock may be used in children. It should not be used by persons who are hypersensitive to this plant. Burdock should be used cautiously by persons with diabetes or cardiac disorders.
SIDE EFFECTS/ADVERSE REACTIONS
CV: Hypotension
ENDO: Hypoglycemia
INTERACTIONS
Drug
Antidiabetics (glyburide, insulin, miglitol): An increased hypoglycemic effect can occur when burdock is taken with antidiabetics; avoid concurrent use.
Antihypertensives, calcium channel blockers: Burdock may possibly increase the hypotensive effect of antihypertensives, calcium channel blockers; avoid concurrent use.
Lab Test
Blood glucose: Burdock may decrease blood glucose level.

SIDE-EFFECTS, TOXICITY
A single report of human poisoning initially associated with burdock has been documented.(20) The patient exhibited symptoms of atropine-like poisoning following the ingestion of a commercially packaged burdock root tea. However, atropine is not a constituent of burdock, and subsequent analysis indicated that the teawas contaminated with a herbal source of solanaceous alkaloids, possibly belladonna leaf. This report served to highlight the problems which may arise with inadequate quality control of herbal preparations.
The carcinogenicity of burdock was investigated in 12 rats fed dried roots (33% of diet) for 120 days, followed by a normal diet until 480 days.(21) Ten of the 12 rats survived 480 days and no tumours were detected. A urinary bladder papilloma and an oligodendroglioma were observed in one rat, but these were considered to have been induced spontaneously. Burdock has been reported to exhibit antitumour properties (see In vitro and animal studies).


CLIENT CONSIDERATIONS
ASSESS
·         Assess the reason the client is using burdock.
·         Monitor blood pressure and blood glucose levels while the client is taking this herb.
·         Assess for the use of antidiabetics, antihypertensives, and calcium channel blockers (see Interactions).
ADMINISTER
·         Instruct the client to store burdock in a tight container away from sunlight and moisture.
TEACH CLIENT/FAMILY
·         Inform the client that pregnancy category is 2 and breastfeeding category is 2A.
·         Inform the client that burdock may be used in children.

PREPARATIONS
PROPRIETARY SINGLE-INGREDIENT PREPARATIONS
Mexico: Saforelle. Portugal: Saforelle.

PROPRIETARY MULTI-INGREDIENT PREPARATIONS
Australia: Acne Oral Spray; Dermaco; Herbal Cleanse; Percutane; Trifolium Complex. Canada: Natural HRT. Czech Republic: Diabetan. France: Arbum; Depuratif Parnel; Fitacnol; Zeniac LP; Zeniac. Malaysia: Celery Plus; Cleansa Plus; Dandelion Complex. South Africa: Lotio Pruni Comp cum Cupro. Spain: Diabesor. UK: Aqua Ban Herbal; Backache; Cascade; Catarrh Mixture; GB Tablets; Gerard House Skin; Gerard House Water Relief Tablets; HRI Clear Complexion; Modern Herbals Water Retention; Napiers Skin Tablets; Rheumatic Pain Remedy; Skin Cleansing; Skin Eruptions Mixture; Tabritis; Tabritis Tablets; Water Naturtabs. USA: Liver Formula Herbal Blend; Skin Hair Nails.

EXTRACTS
High inulin and mucilage may explain GI soothing effect (SKY). The bitter compound artipicrin kills Gram-positive bacteria (CAN). Bitter constituents explain digestive properties (SKY); polyacetylenes are antimicrobial (SKY). Lignans have antileukemic, antilymphomic, antimutagenic, and antitumor activities. (FNF). The burdock fiber (root can be 50% inulin) at 5% in the diet of rats protects against the toxicity of artificial food coloring. Plant juice reduces chromosome aberrations (CAN). Inulin seems to have antidiabetic, gastrostimulant, hypocholesterolemic, hypoglycemic, immunostimulant, and lipolytic activities. Flowers and leaves antibacterial against Bacillus subtilis, Escherichia coli, Mycobacterium smegmatis, Shigella flexneri, Shigella sonnei, and Staphylococcus aureus.


REFERENCE


Barnes, J., Anderson, L. A., and Phillipson, J. D. 2007. Herbal Medicines Third Edition. Pharmaceutical Press. Auckland and London.

Duke, J. A. with Mary Jo Bogenschutz-Godwin, Judi duCellier, Peggy-Ann K. Duke. 2002. Handbook of Medicinal Herbs 2nd Ed. CRC Press LLC. USA.

Gruenwald, J., Brendler, T., Jaenicke, Ch. 2000.  PDR for Herbal Medicines.  Medical Economics Company, Inc. at Montvale, NJ 07645-1742. USA

Linda S-Roth. 2010. Mosby’s Handbook Of Herbs & Natural Supplements, Fourth Edition. Mosby Elsevier. USA

Figure 3. Primary Chemical Components and Possible Actions
(Linda, S-R. 2010)










No comments:

Post a Comment